179 related articles for article (PubMed ID: 19200746)
21. Apolipoprotein M associates to lipoproteins through its retained signal peptide.
Axler O; Ahnström J; Dahlbäck B
FEBS Lett; 2008 Mar; 582(5):826-8. PubMed ID: 18279674
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.
Elsøe S; Ahnström J; Christoffersen C; Hoofnagle AN; Plomgaard P; Heinecke JW; Binder CJ; Björkbacka H; Dahlbäck B; Nielsen LB
Atherosclerosis; 2012 Mar; 221(1):91-7. PubMed ID: 22204862
[TBL] [Abstract][Full Text] [Related]
23. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
Park YJ; Yoo SA; Lee JH; Chung YJ; Cho CS; Kim W-
Clin Exp Rheumatol; 2013; 31(2):180-8. PubMed ID: 23190940
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
[TBL] [Abstract][Full Text] [Related]
25. Characterization of apoM in normal and genetically modified mice.
Faber K; Axler O; Dahlbäck B; Nielsen LB
J Lipid Res; 2004 Jul; 45(7):1272-8. PubMed ID: 15102887
[TBL] [Abstract][Full Text] [Related]
26. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
Nádró B; Juhász L; Szentpéteri A; Páll D; Paragh G; Harangi M
Orv Hetil; 2018 Feb; 159(5):168-175. PubMed ID: 29376427
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of apolipoprotein M and its relation to atherosclerosis and diabetes.
Hu YW; Zheng L; Wang Q
Biochim Biophys Acta; 2010 Feb; 1801(2):100-5. PubMed ID: 19909825
[TBL] [Abstract][Full Text] [Related]
28. Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.
Yi-zhou Y; Bing C; Ming-qiu L; Wei W; Ru-xing W; Jun R; Liu-yan W; Zhao-hui J; Yong J; Guo qing J; Jian Z
Lipids Health Dis; 2012 Dec; 11():168. PubMed ID: 23216709
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the apolipoprotein M signaling pathway: a review.
Cheng G; Zheng L
J Recept Signal Transduct Res; 2022 Jun; 42(3):285-292. PubMed ID: 34006168
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of serum apolipoprotein M level.
Tanaka S; Okamoto Y
Clin Lab; 2011; 57(9-10):803-6. PubMed ID: 22029201
[TBL] [Abstract][Full Text] [Related]
31. Opposite regulation of the human apolipoprotein M gene by hepatocyte nuclear factor 1 and Jun transcription factors.
Mosialou I; Krasagakis K; Kardassis D
J Biol Chem; 2011 May; 286(19):17259-69. PubMed ID: 21454713
[TBL] [Abstract][Full Text] [Related]
32. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M.
Faber K; Hvidberg V; Moestrup SK; Dahlbäck B; Nielsen LB
Mol Endocrinol; 2006 Jan; 20(1):212-8. PubMed ID: 16099815
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein M.
Luo G; Zhang X; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2004 Oct; 3():21. PubMed ID: 15461812
[TBL] [Abstract][Full Text] [Related]
34. Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M.
Wolfrum C; Howell JJ; Ndungo E; Stoffel M
J Biol Chem; 2008 Jun; 283(24):16940-9. PubMed ID: 18381283
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein M regulates the orphan nuclear receptor LRH-1 gene expression through binding to its promoter region in HepG2 cells.
Pan Y; Zhou HG; Zhou H; Hu M; Tang LJ
Drug Des Devel Ther; 2015; 9():2375-82. PubMed ID: 25987835
[TBL] [Abstract][Full Text] [Related]
36. Plasma levels of apolipoprotein M in normal and complicated pregnancy.
Ahnström J; Lindqvist PG; Walle U; Dahlbäck B
Acta Obstet Gynecol Scand; 2010 Sep; 89(9):1214-7. PubMed ID: 20804348
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.
Mulya A; Seo J; Brown AL; Gebre AK; Boudyguina E; Shelness GS; Parks JS
J Lipid Res; 2010 Mar; 51(3):514-24. PubMed ID: 19767535
[TBL] [Abstract][Full Text] [Related]
38. Expression pattern of apolipoprotein M during mouse and human embryogenesis.
Zhang XY; Jiao GQ; Hurtig M; Dong X; Zheng L; Luo GH; Nilsson-Ehle P; Ye Q; Xu N
Acta Histochem; 2004; 106(2):123-8. PubMed ID: 15147633
[TBL] [Abstract][Full Text] [Related]
39. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B
J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127
[TBL] [Abstract][Full Text] [Related]
40. Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats.
Zheng L; Feng Y; Shi Y; Zhang J; Mu Q; Qin L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Luo G; Xu N
PLoS One; 2014; 9(8):e105681. PubMed ID: 25144649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
